Brand-Ad-30-6
 IADVL
Indexed with PubMed and Science Citation Index (E) 
 
Users online: 3091 
     Home | Feedback | Login 
About Current Issue Archive Ahead of print Search Instructions Online Submission Subscribe What's New Contact  
  NAVIGATE Here 
    Next article
    Previous article
    Table of Contents

 RESOURCE Links
    Similar in PUBMED
    Search Pubmed for
    Search in Google Scholar for
  Related articles
    Citation Manager
    Access Statistics
    Reader Comments
    Email Alert *
    Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed12123    
    Printed203    
    Emailed12    
    PDF Downloaded0    
    Comments [Add]    
    Cited by others 6    

Recommend this journal

 

 ORIGINAL ARTICLE
Year : 2002  |  Volume : 68  |  Issue : 2  |  Page : 63--64

Minimal erythema dose (Med) to narrow band ultraviolet - B (NB-UVB) broad band ultraviolet-B (BB-UVB) - A pilot study


Department of Skin & STD, PSG Hospitals, Peelamedu, Coimbatore, Tamil Nadu - 641 004, India

Correspondence Address:
C R Srinivas
Department of Skin & STD, PSG Hospitals, Peelamedu, Coimbatore, Tamil Nadu - 641 004
India
Login to access the Email id

Source of Support: None, Conflict of Interest: None


PMID: 17656878

Rights and PermissionsRights and Permissions

Phototherapy is an effective treatment for various dermatological conditions. Ultraviolet B (290 - 320nm) is reported effective in the treatment of psoriasis. Narrow band UVB (NB-UVB) is also reported effective in the treatment of psoriasis and vitiligo. To standardize the dosage schedule for NB-UVB we undertook this study to determine the minimal erythema dose (MED) on type IV and Indian skin. On six volunteers tested the MED for NB-UVB ranged between 150mj and 400mj and for BB-UVB ranged between 10mj and 35mj. The mean MED for NB was 300mj and BB was 21 mj, the mean ratio of NB to BB was 1:15. We propose that narrow band UVB is a practical alternative to the conventional broad band UVB and has the advantage over photochemotherapy (PUVA) of being effective without prior administration of psoralen.






[FULL TEXT] [PDF Not available]*


        
Print this article     Email this article

Online since 15th March '04
Published by Wolters Kluwer - Medknow